By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Omni Bio Pharmaceutical 

700 17th Street
Suite 1200
Denver  Colorado  80202  U.S.A.
Phone: 303-893-1003 Fax: n/a


Company News
Omni Bio Pharmaceutical To Present At 7th Annual BioPharm America Conference 9/18/2014 1:59:01 PM
Omni Bio Pharmaceutical Appoints Jack Riccardi As Chief Financial Officer 8/14/2014 1:32:10 PM
Omni Bio Pharmaceutical Announces Grant Of New Use Patent In Europe 5/8/2014 8:53:44 AM
Omni Bio Pharmaceutical Appoints Dr. Bruce Forrest To Chief Development Officer Role 5/1/2014 10:00:15 AM
Omni Bio Pharmaceutical Announces Publication Of Its Pilot Study Of Alpha-1 Antitrypsin In Type 1 Diabetes 4/30/2014 11:11:50 AM
Gallus Biopharmaceuticals, LLC Enters Cell Line Optimization And Manufacturing Agreement With Omni Bio Pharmaceutical 4/29/2014 11:17:54 AM
Omni Bio Pharmaceutical Announces $3 Million Private Financing Plan And New Investment Banking Services Advisor 4/25/2014 8:47:48 AM
Omni Bio Pharmaceutical Announces Notice Of Allowance For New Use Patent 11/26/2013 10:11:53 AM
Omni Bio Pharmaceutical Announces Reduction in Inflammatory Myocardial Injury With Its Lead Recombinant Molecule 11/21/2013 11:04:34 AM
Omni Bio Pharmaceutical Announces U.S. Patent Action for Its Recombinant Alpha-1 Antitrypsin Molecule 11/6/2013 10:01:26 AM